TGF‐β plays a role in promoting angiogenesis and immune escape in tumors and can induce the process of epithelial–mesenchymal transition (EMT), which plays an important role in increasing the invasiveness of tumor cells and tumor survival. The gene discussed is TGFB1; the disease is neoplasm.